Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AVRO - AvroBio Inc

Close
1.4
-15.640   -1,117.143%

Share volume: 206,820
Last Updated: Thu 20 Jun 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$17.04
-15.64
-91.78%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 25%
Dept financing 1%
Liquidity 50%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-92.06%
1 Month
-91.61%
3 Months
-90.89%
6 Months
-91.23%
1 Year
-88.99%
2 Year
-87.72%
Key data
Stock price
$1.40
P/E Ratio 
0.00
DAY RANGE
$1.38 - $1.44
EPS 
$0.00
52 WEEK RANGE
$16.56 - $237.60
52 WEEK CHANGE
-$0.88
MARKET CAP 
754.215 M
YIELD 
N/A
SHARES OUTSTANDING 
44.894 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,828
AVERAGE 30 VOLUME 
$2,451
Company detail
CEO:
Region: US
Website: avrobio.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Recent news